0002071165-25-000001.txt : 20250603 0002071165-25-000001.hdr.sgml : 20250603 20250603125117 ACCESSION NUMBER: 0002071165-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250603 DATE AS OF CHANGE: 20250603 EFFECTIVENESS DATE: 20250603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kamau Therapeutics, Inc. CENTRAL INDEX KEY: 0002071165 ORGANIZATION NAME: EIN: 932261495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-547903 FILM NUMBER: 251018102 BUSINESS ADDRESS: STREET 1: 220 E. GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 628-333-5084 MAIL ADDRESS: STREET 1: 220 E. GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0002071165 Kamau Therapeutics, Inc. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 628-333-5084 DELAWARE GEM Biologics, Inc. None Corporation true 2023 Valentin Barsan c/o Kamau Therapeutics, Inc. 220 E. Grand Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Matthew Porteus c/o Kamau Therapeutics, Inc. 220 E. Grand Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Ness Bermingham c/o Kamau Therapeutics, Inc. 220 E. Grand Avenue South San Francisco CA CALIFORNIA 94080 Director Raymond Kelleher c/o Kamau Therapeutics, Inc. 220 E. Grand Avenue South San Francisco CA CALIFORNIA 94080 Director Other Technology Decline to Disclose 06b false 2025-05-19 false true false 0 10000000 4999997 5000003 false 6 0 0 0 false Kamau Therapeutics, Inc. /s/ Valentin Barsan Valentin Barsan Chief Executive Officer 2025-06-03